Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Alvotech (ALVOW) Net Income towards Common Stockholders (2021 - 2025)

Historic Net Income towards Common Stockholders for Alvotech (ALVOW) over the last 5 years, with Q3 2025 value amounting to -$275.9 million.

  • Alvotech's Net Income towards Common Stockholders fell 101455.76% to -$275.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$376.4 million, marking a year-over-year increase of 5924.33%. This contributed to the annual value of -$231.9 million for FY2024, which is 5797.52% up from last year.
  • As of Q3 2025, Alvotech's Net Income towards Common Stockholders stood at -$275.9 million, which was down 101455.76% from $327.9 million recorded in Q2 2025.
  • Alvotech's Net Income towards Common Stockholders' 5-year high stood at $327.9 million during Q2 2025, with a 5-year trough of -$750.4 million in Q4 2023.
  • In the last 5 years, Alvotech's Net Income towards Common Stockholders had a median value of -$106.4 million in 2022 and averaged -$134.6 million.
  • Over the last 5 years, Alvotech's Net Income towards Common Stockholders had its largest YoY gain of 32133.31% in 2025, and its largest YoY loss of 9990000.0% in 2025.
  • Quarter analysis of 5 years shows Alvotech's Net Income towards Common Stockholders stood at $254.0 million in 2021, then tumbled by 332.15% to -$589.7 million in 2022, then decreased by 27.24% to -$750.4 million in 2023, then soared by 72.91% to -$203.3 million in 2024, then tumbled by 35.71% to -$275.9 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$275.9 million for Q3 2025, versus $327.9 million for Q2 2025 and -$225.2 million for Q1 2025.